225 related articles for article (PubMed ID: 21681016)
21. Pharmacogenetics of beta2-agonist drugs in asthma.
Taylor DR
Clin Rev Allergy Immunol; 2006; 31(2-3):247-58. PubMed ID: 17085797
[TBL] [Abstract][Full Text] [Related]
22. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
23. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
Lipworth BJ
Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
[TBL] [Abstract][Full Text] [Related]
24. Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.
Konno S; Makita H; Hasegawa M; Nasuhara Y; Nagai K; Betsuyaku T; Hizawa N; Nishimura M
Pharmacogenet Genomics; 2011 Nov; 21(11):687-93. PubMed ID: 21881540
[TBL] [Abstract][Full Text] [Related]
25. Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
McKinnell RM; Klein U; Linsell MS; Moran EJ; Nodwell MB; Pfeiffer JW; Thomas GR; Yu C; Jacobsen JR
Bioorg Med Chem Lett; 2014 Jul; 24(13):2871-6. PubMed ID: 24835980
[TBL] [Abstract][Full Text] [Related]
26. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
27. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics of chronic obstructive pulmonary disease.
Hizawa N
Pharmacogenomics; 2013 Jul; 14(10):1215-25. PubMed ID: 23859575
[TBL] [Abstract][Full Text] [Related]
29. Risk versus benefit considerations for the beta(2)-agonists.
Kelly HW
Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
[TBL] [Abstract][Full Text] [Related]
30. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
31. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
Metzger NL; Kockler DR; Gravatt LA
Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
[TBL] [Abstract][Full Text] [Related]
32. Beta2-adrenoceptor polymorphisms predict response to beta2-agonists in children with acute asthma.
Martin AC; Zhang G; Rueter K; Khoo SK; Bizzintino J; Hayden CM; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN
J Asthma; 2008 Jun; 45(5):383-8. PubMed ID: 18569231
[TBL] [Abstract][Full Text] [Related]
33. beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.
Taylor DR
Expert Opin Pharmacother; 2007 Dec; 8(18):3195-203. PubMed ID: 18035963
[TBL] [Abstract][Full Text] [Related]
34. Clinical consequences of ADRbeta2 polymorphisms.
Hawkins GA; Weiss ST; Bleecker ER
Pharmacogenomics; 2008 Mar; 9(3):349-58. PubMed ID: 18303970
[TBL] [Abstract][Full Text] [Related]
35. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
36. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N; Yoshikawa T; Kanazawa H; Hirata K; Fujimoto S
Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
[TBL] [Abstract][Full Text] [Related]
37. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
Korsgaard J; Ledet M
Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
[TBL] [Abstract][Full Text] [Related]
38. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
[TBL] [Abstract][Full Text] [Related]
39. The effect of polymorphisms of beta2 adrenoceptors on response to long-acting beta2 agonists in Iranian asthmatic patients.
Soleimani F; Fahimi F; Adimi Naghan P; Nadji SA; Morowati S; Naderi N; Masjedi MR
Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):383-90. PubMed ID: 23996715
[TBL] [Abstract][Full Text] [Related]
40. Role of
Scaparrotta A; Franzago M; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A; Stuppia L
J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):164-173. PubMed ID: 30855197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
